Noboru Nakashima

Learn More
OBJECTIVE This study aimed to assess the efficacy and safety of our newly developed nasal glucagon-like peptide-1 (GLP-1) compound and injector. RESEARCH DESIGN AND METHODS Twenty-six patients with type 2 diabetes were enrolled in this double-blind placebo-controlled study. The nasal compound containing 1.2 mg of human GLP-1 (7-36) amide or placebo was(More)
Readability tests were carried out for three types of displays; a TFT-LCD with backlight of white LED matrices, a TFT-LCD with backlight of two-row cold cathode fluorescent lamps (CCFLs), and a CRT. Readability of the TFT-LCD with backlight of white LED matrices was highest among the others from the viewpoint of flicker and luminance unevenness. The(More)
  • 1